Who are we?
Simpexfarma is a Barcelona based Pharma- consulting company
founded by globally experienced multilingual professionals. We
build our competencies for providing-consulting services to
pharmaceutical, cosmetics, medical device and biotech
companies in order to succeed in the key markets of Eastern Europe,
Middle East and Africa (EEMEA).
Who are we?
Simpexfarma is a Barcelona based Pharma- consulting company
founded by globally experienced multilingual professionals. We
build our competencies for providing-consulting services to
pharmaceutical, cosmetics, medical device and biotech
companies in order to succeed in the key markets of Eastern Europe,
Middle East and Africa (EEMEA).
Simpexfarma's pharmaceutical
consultants work on projects for
pharmaceutical companies in all key
EEMEA markets such as Russia, Turkey,
CIS Countries, Saudi Arabia, UAE. We
aim to help our clients in performing
market research and complete business
plans, finding and signing with the
correct local partner, understanding
local regulations and conducting
healthcare lobbying.
In the recent years, sales of more
sophisticated medical devices are
increasing in the EEMEA region. With
our solid experience, we possess the
knowledge and expertise to help you
succeed in this market.
Simpexfarma's market assessment
tools help our clients to evaluate
cosmetics market and take the
necessary steps to adapt their products
to the needs of targeted market.
Our business consulting process can
help at any stage of your business with
everything from market research to
partner search. We can provide you with
the necessary due diligence to help you
make the right decisions.
- Topnotch market research
- Follow up of local marketing and selling activities
- Implementation of marketing strategies
- Tracking of scientific events
- Yearly sales budgets, forecasts and reports
- Follow up of local stocks
- Launch activities
- Tender markets consultancy.
- Healthcare lobbying
1
Pharmaceutical
export consulting
2
Medical device export
consulting
3
Cosmetic export
consulting
4
Business development
and strategy
What do we do?
1
Pharmaceutical
export consulting
Simpexfarma's pharmaceutical
consultants work on projects for
pharmaceutical companies in all key
EEMEA markets such as Russia, Turkey,
CIS Countries, Saudi Arabia, UAE. We
aim to help our clients in performing
market research and complete business
plans, finding and signing with the
correct local partner, understanding
local regulations and conducting
healthcare lobbying.
What do we do?
2
Medical device
export consulting
In the recent years, sales of more
sophisticated medical devices are
increasing in the EEMEA region. With
our solid experience, we possess the
knowledge and expertise to help you
succeed in this market.
What do we do?
3
Cosmetic export
consulting
Simpexfarma's market assessment
tools help our clients to evaluate
cosmetics market and take the
necessary steps to adapt their products
to the needs of targeted market.
What do we do?
4
Business
development and
strategy
Our business consulting process can
help at any stage of your business with
everything from market research to
partner search. We can provide you with
the necessary due diligence to help you
make the right decisions.
- Topnotch market research
- Follow up of local marketing and selling activities
- Implementation of marketing strategies
- Tracking of scientific events
- Yearly sales budgets, forecasts and reports
- Follow up of local stocks
- Launch activities
- Tender markets consultancy.
- Healthcare lobbying
What do we do?
Why EEMEA region is important
for your business?
EEMEA is a region of great opportunity for all types of
companies - not just large multina-tionals.
Emerging Markets represent 25% of the world’s pharma
market. In Eastern Europe, along with countries
such as Poland, Romania or Ukraine, primarily
Russia and Turkey are two of the seven countries
IMS Health calls the “PHAR-MERGING COUNTRIES”.
Seize the opportunities lying beyond
your comfort zone…
The opportunity
The opportunity
Why EEMEA region is important
for your business?
EEMEA is a region of great opportunity for all types of
companies - not just large multina-tionals.
Emerging Markets represent 25% of the world’s pharma
market. In Eastern Europe, along with countries
such as Poland, Romania or Ukraine, primarily
Russia and Turkey are two of the seven countries
IMS Health calls the “PHAR-MERGING COUNTRIES”.
Seize the opportunities lying beyond
your comfort zone…
In Every Opportunity There Lies Challenge
Simpexfarma's multilingual international consultants can help you
either on selected markets for numerous products or team up with
you on a project-based model and build up a launch plan for
numerous markets for a specific product.
Knowledge of healthcare regulations is essential for international
companies to succeed.
We are a results-driven organization founded by professionals
holding vast experience in pharmaceutical industry.
We know EEMEA and we know it well.
